(EXO) Exor - Overview
Stock: Automobiles, Agricultural Equipment, Sports Cars, Commercial Vehicles, Media
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.57% |
| Yield on Cost 5y | 0.75% |
| Yield CAGR 5y | 5.53% |
| Payout Consistency | 100.0% |
| Payout Ratio | 0.7% |
| Risk 5d forecast | |
|---|---|
| Volatility | 20.5% |
| Relative Tail Risk | -2.15% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.24 |
| Alpha | -31.98 |
| Character TTM | |
|---|---|
| Beta | 0.274 |
| Beta Downside | 0.378 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.29% |
| CAGR/Max DD | -0.08 |
Description: EXO Exor December 17, 2025
Exor N.V. is a diversified holding company that controls leading brands across automotive, industrial, media, and sports sectors, including Ferrari, Stellantis, CNH Industrial, Iveco Group, Juventus FC, and GEDI. Through these subsidiaries it designs, manufactures and sells luxury sports cars, mass-market vehicles, agricultural and construction equipment, powertrain technologies, and a range of media and consumer-goods products.
In FY 2023 the group reported consolidated revenue of roughly €30.5 billion, with Ferrari contributing €5.6 billion and delivering a 12 % increase in net profit year-over-year. Stellantis, Exor’s largest automotive stake, saw EV sales rise about 30 % YoY, reflecting the broader industry shift toward electrification, while CNH Industrial’s order intake grew 7 % in Q3 2024, driven by stronger demand for precision farming equipment. Key macro drivers for Exor’s portfolio include tightening emissions regulations, supply-chain bottlenecks in semiconductors, and inflation-linked cost pressures that affect both consumer-vehicle pricing and industrial-equipment margins.
For a deeper quantitative breakdown, ValueRay’s platform offers granular, real-time metrics on Exor’s holdings.
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income: 16.08b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 11.74 > 1.0 |
| NWC/Revenue: 2.21% < 20% (prev 34.66%; Δ -32.45% < -1%) |
| CFO/TA 0.20 > 3% & CFO 7.87b > Net Income 16.08b |
| Net Debt (-1.53b) to EBITDA (19.77b): -0.08 < 3 |
| Current Ratio: 2.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (207.6m) vs 12m ago -7.78% < -2% |
| Gross Margin: 53.97% > 18% (prev 0.25%; Δ 5372 % > 0.5%) |
| Asset Turnover: 56.71% > 50% (prev 47.09%; Δ 9.61% > 0%) |
| Interest Coverage Ratio: 260.8 > 6 (EBITDA TTM 19.77b / Interest Expense TTM 69.0m) |
Altman Z'' 10.00
| A: 0.02 (Total Current Assets 1.55b - Total Current Liabilities 701.0m) / Total Assets 40.00b |
| B: -0.02 (Retained Earnings -624.0m / Total Assets 40.00b) |
| C: 0.27 (EBIT TTM 18.00b / Avg Total Assets 67.39b) |
| D: 10.35 (Book Value of Equity 37.70b / Total Liabilities 3.64b) |
| Altman-Z'' Score: 12.75 = AAA |
Beneish M -3.37
| DSRI: 0.01 (Receivables 160.0m/29.71b, Revenue 38.21b/44.63b) |
| GMI: 0.46 (GM 53.97% / 24.63%) |
| AQI: 2.44 (AQ_t 0.96 / AQ_t-1 0.39) |
| SGI: 0.86 (Revenue 38.21b / 44.63b) |
| TATA: 0.21 (NI 16.08b - CFO 7.87b) / TA 40.00b) |
| Beneish M-Score: -3.37 (Cap -4..+1) = AA |
What is the price of EXO shares?
Over the past week, the price has changed by -2.47%, over one month by -4.42%, over three months by -9.13% and over the past year by -22.68%.
Is EXO a buy, sell or hold?
What are the forecasts/targets for the EXO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 115.1 | 66.6% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 62.5 | -9.5% |
EXO Fundamental Data Overview January 28, 2026
P/S = 1.7692
P/B = 0.3908
Revenue TTM = 38.21b EUR
EBIT TTM = 18.00b EUR
EBITDA TTM = 19.77b EUR
Long Term Debt = 3.04b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 629.0m EUR (from shortTermDebt, last quarter)
Debt = 3.54b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.53b EUR (from netDebt column, last quarter)
Enterprise Value = 24.75b EUR (22.74b + Debt 3.54b - CCE 1.53b)
Interest Coverage Ratio = 260.8 (Ebit TTM 18.00b / Interest Expense TTM 69.0m)
EV/FCF = 4.07x (Enterprise Value 24.75b / FCF TTM 6.08b)
FCF Yield = 24.58% (FCF TTM 6.08b / Enterprise Value 24.75b)
FCF Margin = 15.92% (FCF TTM 6.08b / Revenue TTM 38.21b)
Net Margin = 42.09% (Net Income TTM 16.08b / Revenue TTM 38.21b)
Gross Margin = 53.97% ((Revenue TTM 38.21b - Cost of Revenue TTM 17.59b) / Revenue TTM)
Gross Margin QoQ = none% (prev 100.0%)
Tobins Q-Ratio = 0.62 (Enterprise Value 24.75b / Total Assets 40.00b)
Interest Expense / Debt = 0.68% (Interest Expense 24.0m / Debt 3.54b)
Taxrate = 0.62% (91.0m / 14.76b)
NOPAT = 17.89b (EBIT 18.00b * (1 - 0.62%))
Current Ratio = 2.21 (Total Current Assets 1.55b / Total Current Liabilities 701.0m)
Debt / Equity = 0.10 (Debt 3.54b / totalStockholderEquity, last quarter 36.35b)
Debt / EBITDA = -0.08 (Net Debt -1.53b / EBITDA 19.77b)
Debt / FCF = -0.25 (Net Debt -1.53b / FCF TTM 6.08b)
Total Stockholder Equity = 34.04b (last 4 quarters mean from totalStockholderEquity)
RoA = 23.87% (Net Income 16.08b / Total Assets 40.00b)
RoE = 47.24% (Net Income TTM 16.08b / Total Stockholder Equity 34.04b)
RoCE = 48.53% (EBIT 18.00b / Capital Employed (Equity 34.04b + L.T.Debt 3.04b))
RoIC = 38.22% (NOPAT 17.89b / Invested Capital 46.80b)
WACC = 6.08% (E(22.74b)/V(26.29b) * Re(6.92%) + D(3.54b)/V(26.29b) * Rd(0.68%) * (1-Tc(0.01)))
Discount Rate = 6.92% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -4.06%
[DCF Debug] Terminal Value 87.80% ; FCFF base≈4.97b ; Y1≈6.13b ; Y5≈10.43b
Fair Price DCF = 1429 (EV 286.47b - Net Debt -1.53b = Equity 288.01b / Shares 201.5m; r=6.08% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -18.74 | EPS CAGR: 477.7% | SUE: -4.0 | # QB: 0
Revenue Correlation: -44.45 | Revenue CAGR: -42.72% | SUE: 1.10 | # QB: 3
EPS next Year (2026-12-31): EPS=1.93 | Chg30d=-1.380 | Revisions Net=-1 | Growth EPS=+113.0% | Growth Revenue=+0.0%